Literature DB >> 12399047

Cloning and characterization of the Burkholderia vietnamiensis norM gene encoding a multi-drug efflux protein.

Christine C Fehlner-Gardiner1, Miguel A Valvano.   

Abstract

Polymyxin B-sensitive mutants in Burkholderia vietnamiensis (Burkholderia cepacia genomovar V) were generated with a mini-Tn5 encoding tetracycline resistance. One of the transposon mutants had an insertion in the norM gene encoding a multi-drug efflux protein. Expression of B. vietnamiensis norM in an Escherichia coli acrAB deletion mutant complemented its norfloxacin hypersensitivity, indicating that the protein functions in drug efflux. However, no effect on antibiotic sensitivity other than sensitivity to polymyxin B was observed in the B. vietnamiensis norM mutant. We demonstrate that increased polymyxin sensitivity in B. vietnamiensis was associated with the presence of tetracycline in the growth medium, a phenotype that was partially suppressed by expression of the norM gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399047     DOI: 10.1111/j.1574-6968.2002.tb11403.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  18 in total

Review 1.  Polymyxin: Alternative Mechanisms of Action and Resistance.

Authors:  Michael J Trimble; Patrik Mlynárčik; Milan Kolář; Robert E W Hancock
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

2.  A Helicobacter pylori TolC efflux pump confers resistance to metronidazole.

Authors:  Karin van Amsterdam; Aldert Bart; Arie van der Ende
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

Review 3.  Antibiotic resistance in Burkholderia species.

Authors:  Katherine A Rhodes; Herbert P Schweizer
Journal:  Drug Resist Updat       Date:  2016-07-30       Impact factor: 18.500

Review 4.  Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

Authors:  Tony Velkov; Kade D Roberts; Roger L Nation; Philip E Thompson; Jian Li
Journal:  Future Microbiol       Date:  2013-06       Impact factor: 3.165

5.  The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients.

Authors:  Matthew T G Holden; Helena M B Seth-Smith; Lisa C Crossman; Mohammed Sebaihia; Stephen D Bentley; Ana M Cerdeño-Tárraga; Nicholas R Thomson; Nathalie Bason; Michael A Quail; Sarah Sharp; Inna Cherevach; Carol Churcher; Ian Goodhead; Heidi Hauser; Nancy Holroyd; Karen Mungall; Paul Scott; Danielle Walker; Brian White; Helen Rose; Pernille Iversen; Dalila Mil-Homens; Eduardo P C Rocha; Arsenio M Fialho; Adam Baldwin; Christopher Dowson; Bart G Barrell; John R Govan; Peter Vandamme; C Anthony Hart; Eshwar Mahenthiralingam; Julian Parkhill
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

Review 6.  Efflux-mediated drug resistance in bacteria.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance.

Authors:  Zhi-Qiang Liu; Peng-Yuan Zheng; Ping-Chang Yang
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

8.  Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo.

Authors:  Tracey A Hunt; Cora Kooi; Pamela A Sokol; Miguel A Valvano
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

9.  Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance.

Authors:  Silvia Buroni; Maria R Pasca; Ronald S Flannagan; Silvia Bazzini; Anna Milano; Iris Bertani; Vittorio Venturi; Miguel A Valvano; Giovanna Riccardi
Journal:  BMC Microbiol       Date:  2009-09-17       Impact factor: 3.605

Review 10.  Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Front Cell Infect Microbiol       Date:  2011-07-22       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.